Vedolizumab has longer persistence than infliximab for ulcerative colitis in a real-world cohort study: Preliminary results from the COMPARE-IT study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY(2023)